Kim SK et al. |
Inflammatory mimetic microfluidic chip by immobilization of cell adhesion molecules for T cell adhesion. |
2012 |
Analyst |
pmid:22822477
|
Menotta M et al. |
Label-free quantification of Tacrolimus in biological samples by atomic force microscopy. |
2015 |
Anal. Chim. Acta |
pmid:26073814
|
Gómez-RÃos GA et al. |
Rapid determination of immunosuppressive drug concentrations in whole blood by coated blade spray-tandem mass spectrometry (CBS-MS/MS). |
2018 |
Anal. Chim. Acta |
pmid:29254576
|
Wada A et al. |
Ribosome display and photo-cross-linking techniques for in vitro identification of target proteins of bioactive small molecules. |
2014 |
Anal. Chem. |
pmid:24380432
|
Hopper JT and Oldham NJ |
Alkali metal cation-induced destabilization of gas-phase protein-ligand complexes: consequences and prevention. |
2011 |
Anal. Chem. |
pmid:21863818
|
Sage L |
Fishing for MAGIC targets. |
2005 |
Anal. Chem. |
pmid:16285140
|
Murakami Y et al. |
On-chip micro-flow polystyrene bead-based immunoassay for quantitative detection of tacrolimus (FK506). |
2004 |
Anal. Biochem. |
pmid:15464959
|
Sellar KJ et al. |
Spectrophotometric assay for calcineurin activity in leukocytes isolated from human blood. |
2006 |
Anal. Biochem. |
pmid:16979577
|
Cañadas O et al. |
Equilibrium studies of a fluorescent tacrolimus binding to surfactant protein A. |
2005 |
Anal. Biochem. |
pmid:15802130
|
Carreras CW et al. |
An FKBP12 binding assay based upon biotinylated FKBP12. |
2001 |
Anal. Biochem. |
pmid:11673895
|
Ahn SC et al. |
A tactic for screening inhibitors of interleukin-2 production. |
2002 |
Anal. Biochem. |
pmid:12018952
|
Park JW et al. |
Liquid chromatography-mass spectrometry characterization of FK506 biosynthetic intermediates in Streptomyces clavuligerus KCTC 10561BP. |
2009 |
Anal. Biochem. |
pmid:19539594
|
Sonatore LM et al. |
The utility of FK506-binding protein as a fusion partner in scintillation proximity assays: application to SH2 domains. |
1996 |
Anal. Biochem. |
pmid:8811923
|
Blanchet B et al. |
Determination of serine/threonine protein phosphatase type 2B PP2B in lymphocytes by HPLC. |
2003 |
Anal. Biochem. |
pmid:12479828
|
Ohtsu Y et al. |
Selective ligand purification using high-performance affinity beads. |
2005 |
Anal. Biochem. |
pmid:15745744
|
Rupprecht KR et al. |
Development of a dot-blot assay for screening monoclonal antibodies to low-molecular-mass drugs. |
2010 |
Anal. Biochem. |
pmid:20696124
|
Nozaki K et al. |
Elimination technique for alkali metal ion adducts from an electrospray ionization process using an on-line ion suppressor. |
2010 |
Anal Sci |
pmid:20543506
|
den Burger JC et al. |
Analysis of cyclosporin A, tacrolimus, sirolimus, and everolimus in dried blood spot samples using liquid chromatography tandem mass spectrometry. |
2012 |
Anal Bioanal Chem |
pmid:22899246
|
Neu V et al. |
On-line solid-phase extraction high-performance liquid chromatography-tandem mass spectrometry for the quantitative analysis of tacrolimus in whole blood hemolyzate. |
2012 |
Anal Bioanal Chem |
pmid:22797715
|
Takahashi T et al. |
Isolating the whole complex of target proteins of FK506 using affinity resins from novel solid phases. |
2006 |
Anal Bioanal Chem |
pmid:16601955
|
Tomás ML |
[Immunosuppressive agents: side effects]. |
1997 |
An R Acad Nac Med (Madr) |
pmid:9616947
|
Navas López VM et al. |
[Safety and efficacy of oral tacrolimus in the treatment of paediatric inflammatory bowel disease]. |
2009 |
An Pediatr (Barc) |
pmid:19427822
|
Zahdi MR et al. |
Erosive pustular dermatosis of the scalp successfully treated with oral prednisone and topical tacrolimus. |
2013 Sep-Oct |
An Bras Dermatol |
pmid:24173187
|
Delgado L et al. |
Zoon's plasma cell balanitis: a report of two cases treated with pimecrolimus. |
2011 Jul-Aug |
An Bras Dermatol |
pmid:22068766
|
Viana Fde O et al. |
Acral lichen sclerosus et atrophicus--case report. |
2011 Jul-Aug |
An Bras Dermatol |
pmid:22068779
|
Cakici O et al. |
Periorbital discoid lupus: a rare localization in a patient with systemic lupus erythematosus. |
|
An Bras Dermatol |
pmid:28300917
|
Lima RS et al. |
Granuloma faciale: a good therapeutic response with the use of topical tacrolimus. |
|
An Bras Dermatol |
pmid:26560220
|
Sisti A et al. |
Effectiveness and safety of topical tacrolimus monotherapy for repigmentation in vitiligo: a comprehensive literature review. |
2016 |
An Bras Dermatol |
pmid:27192518
|
Tamler C et al. |
Tacrolimus 0,1% ointment in the treatment of vitiligo: a series of cases. |
2011 Jan-Feb |
An Bras Dermatol |
pmid:21437550
|
Holmgren G et al. |
Successful pregnancies and fatherhood in familial amyloidotic polyneuropathy (FAP Val30Met) patients with liver transplantation. |
2004 |
Amyloid |
pmid:15478469
|
Fix OK et al. |
Liver transplant alone without kidney transplant for fibrinogen Aα-chain (AFib) renal amyloidosis. |
2016 |
Amyloid |
pmid:26972447
|
Kyles AE et al. |
Comparison of the in vitro antiproliferative effects of five immunosuppressive drugs on lymphocytes in whole blood from cats. |
2000 |
Am. J. Vet. Res. |
pmid:10951980
|
Kyles AE et al. |
Pharmacokinetics of tacrolimus after multidose oral administration and efficacy in the prevention of allograft rejection in cats with renal transplants. |
2003 |
Am. J. Vet. Res. |
pmid:12856780
|
Arango C et al. |
A 29-year-old renal transplant recipient with acute respiratory failure. |
2012 |
Am. J. Trop. Med. Hyg. |
pmid:22665592
|
Djamali A et al. |
Nox2 is a mediator of chronic CsA nephrotoxicity. |
2012 |
Am. J. Transplant. |
pmid:22568654
|
Cavadas PC et al. |
Bilateral trans-humeral arm transplantation: result at 2 years. |
2011 |
Am. J. Transplant. |
pmid:21521475
|
Wen X et al. |
Comparison of Utilization and Clinical Outcomes for Belatacept- and Tacrolimus-Based Immunosuppression in Renal Transplant Recipients. |
2016 |
Am. J. Transplant. |
pmid:27137884
|
Abdelmalek MF et al. |
Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trial. |
2012 |
Am. J. Transplant. |
pmid:22233522
|
Egli A et al. |
Renal failure five years after lung transplantation due to polyomavirus BK-associated nephropathy. |
2010 |
Am. J. Transplant. |
pmid:20840474
|
Touzot M et al. |
Renal transplantation in HIV-infected patients: the Paris experience. |
2010 |
Am. J. Transplant. |
pmid:20840478
|
Gupta G et al. |
Safe Conversion From Tacrolimus to Belatacept in High Immunologic Risk Kidney Transplant Recipients With Allograft Dysfunction. |
2015 |
Am. J. Transplant. |
pmid:25988397
|
Saikali JA et al. |
Sirolimus may promote thrombotic microangiopathy. |
2003 |
Am. J. Transplant. |
pmid:12603218
|
Duncan FJ et al. |
Clinically relevant immunosuppressants influence UVB-induced tumor size through effects on inflammation and angiogenesis. |
2007 |
Am. J. Transplant. |
pmid:17941958
|
Silva HT et al. |
Planned randomized conversion from tacrolimus to sirolimus-based immunosuppressive regimen in de novo kidney transplant recipients. |
2013 |
Am. J. Transplant. |
pmid:24266969
|
Ricciardelli I et al. |
Rapid generation of EBV-specific cytotoxic T lymphocytes resistant to calcineurin inhibitors for adoptive immunotherapy. |
2013 |
Am. J. Transplant. |
pmid:24266973
|
Suszynski TM et al. |
Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation. |
2013 |
Am. J. Transplant. |
pmid:23432755
|
Damon C et al. |
Predictive Modeling of Tacrolimus Dose Requirement Based on High-Throughput Genetic Screening. |
2017 |
Am. J. Transplant. |
pmid:27597269
|
McKenna G and Trotter JF |
Does early (CNI) conversion lead to eternal (renal) salvation? |
2010 |
Am. J. Transplant. |
pmid:20928938
|
Shuker N et al. |
A Randomized Controlled Trial Comparing the Efficacy of Cyp3a5 Genotype-Based With Body-Weight-Based Tacrolimus Dosing After Living Donor Kidney Transplantation. |
2016 |
Am. J. Transplant. |
pmid:26714287
|
Hanto DW et al. |
Intraoperative administration of inhaled carbon monoxide reduces delayed graft function in kidney allografts in Swine. |
2010 |
Am. J. Transplant. |
pmid:20977633
|
Al-Massarani G et al. |
Impact of immunosuppressive treatment on endothelial biomarkers after kidney transplantation. |
2008 |
Am. J. Transplant. |
pmid:18925903
|
Frassetto LA and Benet LZ |
Pharmacogenomics and transplantation: where are we? |
2004 |
Am. J. Transplant. |
pmid:15147415
|
MacPhee IA et al. |
The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation. |
2004 |
Am. J. Transplant. |
pmid:15147425
|
Artz MA et al. |
Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile. |
2004 |
Am. J. Transplant. |
pmid:15147428
|
Koefoed-Nielsen PB et al. |
Blood tacrolimus levels and calcineurin phosphatase activity early after renal transplantation. |
2002 |
Am. J. Transplant. |
pmid:12099520
|
Arnold R et al. |
Association between calcineurin inhibitor treatment and peripheral nerve dysfunction in renal transplant recipients. |
2013 |
Am. J. Transplant. |
pmid:23841745
|
Hirsch HH et al. |
BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP-12. |
2016 |
Am. J. Transplant. |
pmid:26639422
|
Willicombe M et al. |
Outcome of patients with preformed donor-specific antibodies following alemtuzumab induction and tacrolimus monotherapy. |
2011 |
Am. J. Transplant. |
pmid:21299828
|
Muthusamy AS et al. |
Alemtuzumab induction and steroid-free maintenance immunosuppression in pancreas transplantation. |
2008 |
Am. J. Transplant. |
pmid:18828772
|
Srinivas TR et al. |
The noninferiority trial: don't don't do it. |
2010 |
Am. J. Transplant. |
pmid:21087412
|
Vanrenterghem Y et al. |
Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial. |
2005 |
Am. J. Transplant. |
pmid:15636615
|
Sindhi R et al. |
Enhanced donor-specific alloreactivity occurs independently of immunosuppression in children with early liver rejection. |
2005 |
Am. J. Transplant. |
pmid:15636616
|
Shergill AK et al. |
Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation. |
2005 |
Am. J. Transplant. |
pmid:15636619
|
Bryan CF et al. |
Long-term survival of kidneys transplanted from live A2 donors to O and B recipients. |
2007 |
Am. J. Transplant. |
pmid:17359511
|
Tydén G et al. |
ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. |
2005 |
Am. J. Transplant. |
pmid:15636623
|
Vincenti F et al. |
Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. |
2007 |
Am. J. Transplant. |
pmid:17359512
|
RodrÃguez-Perálvarez M et al. |
Tacrolimus exposure after liver transplantation in randomized controlled trials: too much for too long. |
2013 |
Am. J. Transplant. |
pmid:23621166
|
Vanhove T et al. |
Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ Recipients. |
2017 |
Am. J. Transplant. |
pmid:28224698
|
Bhorade SM et al. |
Comparison of three tacrolimus-based immunosuppressive regimens in lung transplantation. |
2003 |
Am. J. Transplant. |
pmid:14629288
|
Madeleine MM et al. |
HPV-related cancers after solid organ transplantation in the United States. |
2013 |
Am. J. Transplant. |
pmid:24119294
|
Pondrom S |
The AJT report. |
2008 |
Am. J. Transplant. |
pmid:18324976
|
De Simone P et al. |
Everolimus with reduced tacrolimus in liver transplantation. |
2013 |
Am. J. Transplant. |
pmid:23601137
|
Shihab F et al. |
Association of Clinical Events With Everolimus Exposure in Kidney Transplant Patients Receiving Low Doses of Tacrolimus. |
2017 |
Am. J. Transplant. |
pmid:28141897
|
Chodoff L and Hamberg KJ |
Response to 'Different preparations of tacrolimus and medication errors'. |
2009 |
Am. J. Transplant. |
pmid:19392982
|
Cherukuri A et al. |
An analysis of lymphocyte phenotype after steroid avoidance with either alemtuzumab or basiliximab induction in renal transplantation. |
2012 |
Am. J. Transplant. |
pmid:22390816
|
Pascher A et al. |
Protein kinase C inhibitor sotrastaurin in de novo liver transplant recipients: a randomized phase II trial. |
2015 |
Am. J. Transplant. |
pmid:25677074
|
O'Connell PJ et al. |
Multicenter Australian trial of islet transplantation: improving accessibility and outcomes. |
2013 |
Am. J. Transplant. |
pmid:23668890
|
Barth RN et al. |
Vascularized bone marrow-based immunosuppression inhibits rejection of vascularized composite allografts in nonhuman primates. |
2011 |
Am. J. Transplant. |
pmid:21668624
|
Chen G et al. |
A synergistic effect between PG490-88 and tacrolimus prolongs renal allograft survival in monkeys. |
2006 |
Am. J. Transplant. |
pmid:16539628
|
Guirado L et al. |
Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients. |
2011 |
Am. J. Transplant. |
pmid:21668633
|
Flechner SM et al. |
The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients. |
2011 |
Am. J. Transplant. |
pmid:21668635
|
Budde K |
How to use mTOR inhibitors? The search goes on. |
2011 |
Am. J. Transplant. |
pmid:21668636
|
Chen G et al. |
Anti-CD45RB monoclonal antibody prolongs renal allograft survival in cynomolgus monkeys. |
2007 |
Am. J. Transplant. |
pmid:17227555
|
Servais A et al. |
Interstitial fibrosis evolution on early sequential screening renal allograft biopsies using quantitative image analysis. |
2011 |
Am. J. Transplant. |
pmid:21672152
|
Maes BD et al. |
Differential effect of diarrhea on FK506 versus cyclosporine A trough levels and resultant prevention of allograft rejection in renal transplant recipients. |
2002 |
Am. J. Transplant. |
pmid:12484345
|
Schrepfer S et al. |
Effect of inhaled tacrolimus on cellular and humoral rejection to prevent posttransplant obliterative airway disease. |
2007 |
Am. J. Transplant. |
pmid:17532751
|
Asberg A et al. |
Effects of the intensity of immunosuppressive therapy on outcome of treatment for CMV disease in organ transplant recipients. |
2010 |
Am. J. Transplant. |
pmid:20486914
|
Ryan CM and Swanson DP |
clinical research, innovative practice and IRB review: identifying and respecting boundaries. |
2007 |
Am. J. Transplant. |
pmid:17331113
|
Hautz T et al. |
Molecular markers and targeted therapy of skin rejection in composite tissue allotransplantation. |
2010 |
Am. J. Transplant. |
pmid:20353468
|
Silva HT et al. |
One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients. |
2007 |
Am. J. Transplant. |
pmid:17217442
|
Nijhoff MF et al. |
Glycemic Stability Through Islet-After-Kidney Transplantation Using an Alemtuzumab-Based Induction Regimen and Long-Term Triple-Maintenance Immunosuppression. |
2016 |
Am. J. Transplant. |
pmid:26288226
|
Chamie K et al. |
The effect of sirolimus on prostate-specific antigen (PSA) levels in male renal transplant recipients without prostate cancer. |
2008 |
Am. J. Transplant. |
pmid:18853950
|
Lefaucheur C et al. |
Renal histopathological lesions after lung transplantation in patients with cystic fibrosis. |
2008 |
Am. J. Transplant. |
pmid:18671673
|
Tedesco-Silva H et al. |
Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses. |
2015 |
Am. J. Transplant. |
pmid:25988935
|
Pech T et al. |
Intestinal regeneration, residual function and immunological priming following rescue therapy after rat small bowel transplantation. |
2012 |
Am. J. Transplant. |
pmid:22974463
|
Gallon L et al. |
Long-term renal allograft function on a tacrolimus-based, pred-free maintenance immunosuppression comparing sirolimus vs. MMF. |
2006 |
Am. J. Transplant. |
pmid:16827862
|
Grenda R et al. |
A prospective, randomized, multicenter trial of tacrolimus-based therapy with or without basiliximab in pediatric renal transplantation. |
2006 |
Am. J. Transplant. |
pmid:16827869
|
Haufroid V et al. |
CYP3A5 and ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant candidates: guidelines from an experimental study. |
2006 |
Am. J. Transplant. |
pmid:17049058
|
Lake JR et al. |
Addition of MMF to dual immunosuppression does not increase the risk of malignant short-term death after liver transplantation. |
2005 |
Am. J. Transplant. |
pmid:16303011
|
Chhabra D et al. |
Impact of calcineurin-inhibitor conversion to mTOR inhibitor on renal allograft function in a prednisone-free regimen. |
2013 |
Am. J. Transplant. |
pmid:24007570
|